Mastercard (MA) faces headline risks from proposed credit card rate caps and the Credit Card Competition Act (CCCA), but I view the odds of enactment as low. MA's moat, technical strength, and resilient business model support a buy rating, with institutional sentiment remaining constructive despite a recent 6% share price pullback. Even in a worst-case CCCA scenario, only 6–9% of MA's net revenue is directly exposed, with estimated EPS impact capped at 2–3.6%.
MasterCard (MA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MasterCard (MA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Mastercard , Visa and British fintech Revolut on Thursday lost a legal challenge to Britain's payments regulator over its plans to introduce a cap on cross-border card fees.
MA bets that category-specific prepaid rewards for fuel, EV charging and groceries can turn incentive spend into steadier, recurring network growth.
The latest trading day saw MasterCard (MA) settling at $566.28, representing a -1.61% change from its previous close.
Artificial intelligence could soon transform online "window shopping." That could bode well for some fintech stocks.
MA is expanding beyond payments by backing Obol's AI cash flow tools in Australia, pushing deeper into SMEs' financial decisions.
MA shares jump 7.6% in a month as investors rotate from AI trades toward durable payment networks with steady growth drivers.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.